The back story: The risk of shingles, a painful and often debilitating reactivation of chickenpox, can be lowered by a vaccine with the trade name Zostavax. It's not perfect: the vaccine lowers the risk of shingles by about 50% in older adults and reduces the risk of a nasty complication--postherpetic neuralgia (terrible persistent pain after the skin symptoms go away)--by close to 70%. Result: The CDC recommends that everyone age 60 and older get vaccinated.
Now the story: For ages, doctors have thought that shingles was a one-time deal and that one episode protected you from subsequent episodes unless your immune system was punky. But according to a study in the current issue of Mayo Clinic Proceedings, the risk of shingles appears to be the same whether you've already had it--or not. Investigators looked at data from 1700 people who had a first episode of shingles and followed them for an average of 8 years. They found that 5% had a second episode; if they had been looking at a similar population of folks who had never had shingles, they would have expected about the same percentage to get shingles. The risk of a second episode was higher among women and in people who'd had pain for 30 or more days after the first one. You can read the summary of the original article or read the story at ScienceDaily.
Should people who've had shingles should get the vaccine to protect against another shingles outbreak?To my knowledge, no one has looked at the effectiveness of the vaccine when given to people who've already had shingles, so there's no data on which to base that decision. I hope my mother is reading. Stay tuned.



